Steroid hormone secretion after stimulation of mineralocorticoid and NMDA receptors and cardiovascular risk in patients with depression
Open Access
- 20 April 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Translational Psychiatry
- Vol. 10 (1), 1-10
- https://doi.org/10.1038/s41398-020-0789-7
Abstract
Major depressive disorder (MDD) is associated with altered mineralocorticoid receptor (MR) and glucocorticoid receptor function, and disturbed glutamatergic signaling. Both systems are closely intertwined and likely contribute not only to the pathophysiology of MDD, but also to the increased cardiovascular risk in MDD patients. Less is known about other steroid hormones, such as aldosterone and DHEA-S, and how they affect the glutamatergic system and cardiovascular disease risk in MDD. We examined salivary cortisol, aldosterone, and DHEA-S secretion after stimulation of MR and glutamatergic NMDA receptors in 116 unmedicated depressed patients, and 116 age- and sex-matched healthy controls. Patients (mean age = 34.7 years, SD = +/- 13.3; 78% women) and controls were randomized to four conditions: (a) control condition (placebo), (b) MR stimulation (0.4 mg fludrocortisone), (c) NMDA stimulation (250 mg D-cycloserine (DCS)), and (d) combined MR/NMDA stimulation (fludrocortisone + DCS). We additionally determined the cardiovascular risk profile in both groups. DCS had no effect on steroid hormone secretion, while cortisol secretion decreased in both fludrocortisone conditions across groups. Independent of condition, MDD patients showed (1) increased cortisol, increased aldosterone, and decreased DHEA-S concentrations, and (2) increased glucose levels and decreased high-density lipoprotein cholesterol levels compared with controls. Depressed patients show profound alterations in several steroid hormone systems that are associated both with MDD pathophysiology and increased cardiovascular risk. Prospective studies should examine whether modulating steroid hormone levels might reduce psychopathology and cardiovascular risk in depressed patients.Funding Information
- Deutsche Forschungsgemeinschaft
This publication has 85 references indexed in Scilit:
- Psychopathological Symptoms in Patients with Primary Hyperaldosteronism - Possible PathwaysHormone and Metabolic Research, 2012
- The stressed synapse: the impact of stress and glucocorticoids on glutamate transmissionNature Reviews Neuroscience, 2011
- Association of Diurnal Patterns in Salivary Cortisol with All-Cause and Cardiovascular Mortality: Findings from the Whitehall II StudyJournal of Clinical Endocrinology & Metabolism, 2011
- Depression and Hypothalamic-Pituitary-Adrenal Activation: A Quantitative Summary of Four Decades of ResearchPsychosomatic Medicine, 2011
- Urinary Cortisol and Six-Year Risk of All-Cause and Cardiovascular MortalityJournal of Clinical Endocrinology & Metabolism, 2010
- Salivary cortisol in depressed patients versus control persons: A systematic review and meta-analysisPsychoneuroendocrinology, 2010
- Aldosterone: A forgotten mediator of the relationship between psychological stress and heart diseaseNeuroscience & Biobehavioral Reviews, 2010
- The Biological Actions of Dehydroepiandrosterone Involves Multiple ReceptorsDrug Metabolism Reviews, 2006
- Increased Plasma Aldosterone in Patients with Clinical DepressionArchives of Medical Research, 2005
- Physiological activity and receptor binding of 9α fluorohydrocortisoneBiochemical and Biophysical Research Communications, 1977